(6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-2-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,3-f]isoquinoline;(6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-3-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,5-f]isoquinoline
C46H48Br2F6N8O2 — CID 160814391
Data last refreshed: (MolForge compound catalog, from PubChem)
About (6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-2-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,3-f]isoquinoline;(6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-3-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,5-f]isoquinoline
(6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-2-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,3-f]isoquinoline;(6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-3-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,5-f]isoquinoline (PubChem CID 160814391) has the molecular formula C46H48Br2F6N8O2 and a molecular weight of 1018.74 g/mol. Its IUPAC name is (6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-2-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,3-f]isoquinoline;(6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-3-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,5-f]isoquinoline.
Molecular Properties
| Compound Name | (6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-2-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,3-f]isoquinoline;(6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-3-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,5-f]isoquinoline |
|---|---|
| PubChem CID | 160814391 |
| Molecular Formula | C46H48Br2F6N8O2 |
| Molecular Weight | 1018.74 g/mol |
| Exact Mass | 1016.22 |
| IUPAC Name | (6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-2-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,3-f]isoquinoline;(6S,8R)-6-(5-bromo-2-pyridinyl)-8-methyl-3-(oxan-2-yl)-7-(2,2,2-trifluoroethyl)-8,9-dihydro-6H-pyrazolo[4,5-f]isoquinoline |
| SMILES | C[C@@H]1Cc2c(ccc3c2cnn3C2CCCCO2)[C@@H](c2ccc(Br)cn2)N1CC(F)(F)F.C[C@@H]1Cc2c(ccc3nn(C4CCCCO4)cc23)[C@@H](c2ccc(Br)cn2)N1CC(F)(F)F |
| InChI | InChI=1S/2C23H24BrF3N4O/c1-14-10-17-16(6-8-19-18(17)12-31(29-19)21-4-2-3-9-32-21)22(30(14)13-23(25,26)27)20-7-5-15(24)11-28-20;1-14-10-17-16(6-8-20-18(17)12-29-31(20)21-4-2-3-9-32-21)22(30(14)13-23(25,26)27)19-7-5-15(24)11-28-19/h2*5-8,11-12,14,21-22H,2-4,9-10,13H2,1H3/t2*14-,21?,22+/m11/s1 |
| InChIKey | SESFXUDYOUJPDC-CCHCUUBTSA-N |
| XLogP | 11.58 |
| TPSA | 86.36 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 64 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1018.74 |
| LogP ≤ 5 | 11.58 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160814391 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.